Skip to main content
CNTX logo

CNTX · Context Therapeutics Inc. · Executive Compensation

Track CNTX — free
$0.24 +0.00 (+1.57%) At close · Oct 23
Market Cap
$21.99M
Shares
91.88M
Volume · Oct 23 1.49M Avg daily vol (3M) 1.55M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Martin Lehr $1,465,430
Jennifer Minai-Azary $866,139
Alex Levit $816,671
Fiscal 2024
Executive Total
Martin Lehr $1,011,069
Jennifer Minai-Azary $698,968
Alex Levit $670,653
Fiscal 2023
Executive Total
Martin Lehr $860,681
Jennifer Minai-Azary $606,676
Alex Levit $582,148
Fiscal 2022
Executive Total
Martin Lehr $1,057,653
Jennifer Minai-Azary $680,668
Alex Levit $653,100
Fiscal 2021
Executive Total
Martin Lehr $1,587,791
Alex Levit $596,709
Jennifer Minai-Azary $322,175
Fiscal 2020
Executive Total
Martin Lehr $250,000

Executive changes

Person Change Filed
Andy Pasternak Appointed 2025-01-13
Richard Berman Resigned 2025-01-13
Dr. Luke Walker Appointed 2024-09-04
Dr. Karen L. Smith Appointed 2024-09-04

Leadership

Key facts CIK 1842952 CUSIP 21077P108 13F (30d) 11 filings 11 filers Visit website Investor relations